Owner RIKEN

Inventors SHIBUYA, Akira

Pub. Number AU-A-2003284432

PCT Number PCT/JP2003/0149

PCT Pub. Number WO2004/048574

Priority 2002-341195 25.11.02 JP

Filing date 21 November 2003

Wipo publication date 18 June 2004

C12N 015/13 Mutation or genetic engineering - Immunoglobulins

C12N 001/15 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 001/19 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 001/21 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 005/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C07K 014/705 Peptides having more than 20 amino acids

C07K 016/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12P 021/02 Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 033/15 Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 033/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 033/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 033/566 Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

A61K 031/7088 - Compounds having three or more nucleosides or nucleotides

A61K 038/00 Medicinal preparations containing peptides

A61K 045/00 Medicinal preparations containing active ingredients not provided for in groups

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 003/10 Drugs for disorders of the metabolism

A61P 007/06 Drugs for disorders of the blood or the extracellular fluid

A61P 011/02 Drugs for disorders of the respiratory system

A61P 011/06 Drugs for disorders of the respiratory system

A61P 017/00 Drugs for dermatological disorders

A61P 017/04 Drugs for dermatological disorders

A61P 017/02 Drugs for dermatological disorders

A61P 019/02 Drugs for skeletal disorders

A61P 021/00 Drugs for disorders of the muscular or neuromuscular system

A61P 025/00 Drugs for disorders of the nervous system

A61P 027/02 Drugs for disorders of the senses

A61P 029/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 035/00 Antineoplastic agents

A61P 035/02 Antineoplastic agents

A61P 037/02 Drugs for immunological or allergic disorders

A61P 037/04 Drugs for immunological or allergic disorders

A61P 037/06 Drugs for immunological or allergic disorders

A61P 037/08 Drugs for immunological or allergic disorders

A61P 043/00 Drugs for specific purposes, not provided for in groups